NCT03153436

Brief Summary

The objective of this study is to evaluate the effect of in-vitro myoinositol supplementation of human sperm on the outcome of cryopreservation.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
41

participants targeted

Target at P50-P75 for phase_1

Timeline
Completed

Started Aug 2016

Shorter than P25 for phase_1

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 28, 2016

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 26, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 26, 2017

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

May 11, 2017

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 15, 2017

Completed
Last Updated

May 16, 2017

Status Verified

May 1, 2017

Enrollment Period

8 months

First QC Date

May 11, 2017

Last Update Submit

May 13, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Cryo-survival rate

    Post-thawing cryo-survival rates of both aliquots ( myo and control) are compared in both groups (A and B).

    7 months

Study Arms (2)

Normal S.A group

ACTIVE COMPARATOR

Infertile men with normal semen analysis. each sample is divided into 2 identical aliquots: one aliquot (Myo aliquot) is supplied with myoinositol, The other aliquot is left as it is (control aliquot).

Biological: Myoinositol

Abnormal S.A group

ACTIVE COMPARATOR

Infertile men with abnormal semen analysis. each sample is divided into 2 identical aliquots: one aliquot (Myo aliquot) is supplied with myoinositol, The other aliquot is left as it is (control aliquot).

Biological: Myoinositol

Interventions

MyoinositolBIOLOGICAL
Abnormal S.A groupNormal S.A group

Eligibility Criteria

Age20 Years - 60 Years
Sexmale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Infertile men with normal or abnormal semen analysis

You may not qualify if:

  • Azoospermic samples

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (6)

  • Ackerman DR. The effect of cooling and freezing on the aerobic and anaerobic lactic acid production of human semen. Fertil Steril. 1968 Jan-Feb;19(1):123-8. doi: 10.1016/s0015-0282(16)36552-9. No abstract available.

    PMID: 4952185BACKGROUND
  • Anger JT, Gilbert BR, Goldstein M. Cryopreservation of sperm: indications, methods and results. J Urol. 2003 Oct;170(4 Pt 1):1079-84. doi: 10.1097/01.ju.0000084820.98430.b8.

    PMID: 14501696BACKGROUND
  • Araki Y, Yao T, Asayama Y, Matsuhisa A, Araki Y. Single human sperm cryopreservation method using hollow-core agarose capsules. Fertil Steril. 2015 Oct;104(4):1004-1009. doi: 10.1016/j.fertnstert.2015.06.043. Epub 2015 Jul 21.

    PMID: 26207962BACKGROUND
  • Bahat A, Eisenbach M. Human sperm thermotaxis is mediated by phospholipase C and inositol trisphosphate receptor Ca2+ channel. Biol Reprod. 2010 Mar;82(3):606-16. doi: 10.1095/biolreprod.109.080127. Epub 2009 Dec 2.

    PMID: 19955332BACKGROUND
  • Beemster P, Groenen P, Steegers-Theunissen R. Involvement of inositol in reproduction. Nutr Rev. 2002 Mar;60(3):80-7. doi: 10.1301/00296640260042748.

    PMID: 11908744BACKGROUND
  • Oberoi B, Kumar S, Talwar P. Study of human sperm motility post cryopreservation. Med J Armed Forces India. 2014 Oct;70(4):349-53. doi: 10.1016/j.mjafi.2014.09.006. Epub 2014 Oct 16.

    PMID: 25382909BACKGROUND

MeSH Terms

Interventions

Inositol

Intervention Hierarchy (Ancestors)

Sugar AlcoholsAlcoholsOrganic ChemicalsCarbohydrates

Study Officials

  • Ramadan Saleh, M.D.

    Sohag University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.B.B.Ch.

Study Record Dates

First Submitted

May 11, 2017

First Posted

May 15, 2017

Study Start

August 28, 2016

Primary Completion

April 26, 2017

Study Completion

April 26, 2017

Last Updated

May 16, 2017

Record last verified: 2017-05